WST SG&A Expense Growth

West Pharmaceutical Services · SG&A Expense Growth

WST logo

WST SG&A Expense Growth

Latest reported16.13%
WST FY SG&A Growth (YoY) (0.00% → 16.13%)
High-resolution chart · PNG

WST sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
16.13%
-4.2162%
11.5178%
-12.4344%
19.8344%
10.7444%
3.7277%
6.8699%
2.5855%
2.9185%
1.8802%
-2.6394%
7.7029%
14.1287%
1.8114%
5.6275%
11.5505%
4.459%
5.3177%
28.8256%
15.6379%
-12.4324%
34.3826%
12.5341%
8.4195%
-13.0937%
10.4965%
0.4274%
-3.5714%
4.1488%
1.3043%
8.6614%
11.2084%
-32.8235%
47.0588%
26.7544%
9.8795%
28.882%
7.6923%
12.406%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.